NCOG-34. AN ASSESSMENT OF OVERALL SURVIVAL AND PALLIATIVE CARE USE AMONG PATIENTS WITH GLIOSARCOMA DIAGNOSED OVER A TWELVE-YEAR SPAN

Gliosarcoma (GS), a rare variant of glioblastoma, accounts for less than 5% of CNS tumors. Due to its low incidence and prevalence, very few comprehensive, large-scale studies are reported in the literature that describe prognostic elements and treatment outcomes. The objective of the study was to e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Boisclair, Stephanie, Samuels, Shenae, Raez, Luis E, Wietecha, Delia A, Cohen, Alejandro Lopez, Khunger, Arjun, King, Kelly, Sareli, Candice, Adames, Jorges, Jacques, Jessica, Salzberg, Mathew, Hunis, Brian, Vulfovich, Michel, Hussein, Atif M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Outcome Measures and Neuro-Cognitive Outcomes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651673/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.572
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars